Thursday, March 28, 2024 | Ramadan 17, 1445 H
broken clouds
weather
OMAN
23°C / 23°C
EDITOR IN CHIEF- ABDULLAH BIN SALIM AL SHUEILI

Trio win Nobel for medicine

1335093
1335093
minus
plus

STOCKHOLM: Three researchers from the US and Britain on Monday shared the Nobel Medicine Prize for research into how human cells sense and adapt to changing oxygen levels, opening up new strategies to fight common diseases such as cancer and anaemia.


William Kaelin and Gregg Semenza of the US and Britain’s Peter Ratcliffe split the nine million Swedish kronor ($914,000, 833,000 euros) award.


While the fact that humans need oxygen to survive has been understood for centuries, how the body registers and responds to oxygen was little known prior to the trio’s pioneering work.


“They established the basis for our understanding of how oxygen levels affect cellular metabolism and physiological function,” the jury said.


Semenza studied a gene known as EPO which causes the body to create more red blood cells and isolated the specific DNA segments that help it to adapt to low oxygen levels.


Radcliffe and Semenza then applied this knowledge to show that the oxygen sensing mechanism was present in virtually all human tissues.


Kaelin identified another gene, present in patients with a genetic disorder that puts them at far greater risk of certain cancers. The gene rewires the body’s ability to prevent the onset of cancer, and it plays a key role in how cancer cells respond to low oxygen levels.


Their work has shed new light on the specific, cell-level processes the body undergoes when low on oxygen — from helping our muscles function during exercise to adapting to life at high altitude.


Cells’ oxygen-sensing ability is also essential during fetal development and in creating new blood vessels.


Drugs being developed


A large number of diseases are linked to EPO, including renal failure and severe anaemia.


Cancerous tumours use the body’s oxygen-regulating tools to hijack blood vessel formation and allow the cancer cells to spread. The Nobel committee said on Monday that several trials were under way developing drugs to interrupt this process, potentially short-circuiting tumour growth. — AFP


SHARE ARTICLE
arrow up
home icon